The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated×2•Originally published 27 April 2026•Updated 28 April 2026•

1 min read

Quest Diagnostics Prices $500 Million Senior Notes Offering at 5.000%

Key Facts

1Quest Diagnostics announced the pricing of a public offering of $500 million aggregate principal amount of senior notes.

2The notes are due in 2036 and carry a coupon rate of 5.000%.

Quest Diagnostics (NYSE: DGX) has priced its public offering of $500 million in senior unsecured notes due June 30, 2036, with a 5.000% annual coupon. The notes were priced at 98.751% of the principal amount, yielding approximate net proceeds of $490.5 million for the company. Quest Diagnostics intends to use these proceeds to fully repay $500 million of its 3.45% senior notes maturing on June 1, 2026. This refinancing initiative follows the company's robust first-quarter financial results and an upward revision of its full-year guidance. The move underscores a proactive approach to managing debt maturity profiles and optimizing capital structure. Analysts view the offering as a strategic step to lock in long-term financing while maintaining a solid investment-grade standing.

about 1 month ago

Version History

Version 2about 1 month ago

What changed: Updated to include the specific pricing at 98.751% of principal, the estimated net proceeds of $490.5 million, and the exact maturity date of June 30, 2036.

Version 1about 1 month ago

What changed: Identified the specific debt being refinanced (3.45% notes due June 2026), the expected closing date of May 6, 2026, and added the DGX ticker symbol.